Kerry Green, MD
Family Medicine · Mesa, AZNPI 1801835350
Payments from drug & device makers
Across 147 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$265
- AbbVie$229
- GSK$199
- Johnson & Johnson$189
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$150
- Novo Nordisk$132
- plus $1K from 35 others
What the payments were for
- Food & beverage$2,592100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $265 |
| AbbVie(2 entities) | 12 | $229 |
| GSK | 11 | $199 |
| Johnson & Johnson | 11 | $189 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $150 |
| Novo Nordisk | 8 | $132 |
| Boehringer Ingelheim | 7 | $124 |
| Amgen(2 entities) | 7 | $113 |
| Astellas Pharma US Inc | 5 | $103 |
| Mylan Specialty L.p. | 7 | $88 |
| Boston Scientific | 4 | $87 |
| Dexcom, Inc. | 3 | $67 |
| Merck | 4 | $60 |
| Lucid Diagnostics Inc. | 1 | $59 |
| Pfizer | 4 | $56 |
| Sunovion Pharmaceuticals Inc. | 2 | $50 |
| Novartis | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Almatica Pharma LLC | 2 | $44 |
| Bayer | 3 | $41 |
| Exact Sciences | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| AstraZeneca | 3 | $34 |
| Viatris Specialty LLC | 1 | $27 |
| Averitas Pharma Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Nevro Corp. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Coloplast | 1 | $18 |
| Teleflex LLC | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Impulse Dynamics (USA) Inc. | 1 | $15 |
| Saluda Medical Americas, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Vertos Medical, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Sonex Health, Inc. | 1 | $9 |
How this compares
$2,592 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 199 | $250,799 |
| TrulicityDulaglutide | 82 | $171,540 |
| JardianceEmpagliflozin | 99 | $147,541 |
| OzempicSemaglutide | 76 | $109,122 |
| XareltoRivaroxaban | 47 | $67,600 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $29,171 |
| LinzessLinaclotide | 21 | $28,963 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $28,796 |
| MyrbetriqMirabegron | 30 | $23,481 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $22,480 |
| JanuviaSitagliptin Phosphate | 14 | $20,459 |
| Spiriva RespimatTiotropium Bromide | 17 | $18,036 |
| GemtesaVibegron | 13 | $13,672 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $13,491 |
| TradjentaLinagliptin | 16 | $13,454 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Prempro | $56 | $254,042213 claims |
| Lilly USA, LLCTrulicity, Humalog | $15 | $179,07896 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $124 | $179,031132 claims |
| Novo NordiskOzempic | $132 | $109,12276 claims |
| Johnson & JohnsonXarelto | $189 | $67,60047 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $199 | $35,97137 claims |
| AbbVieLinzess | $229 | $28,96321 claims |
| Astellas Pharma US IncMyrbetriq | $103 | $23,48130 claims |
| MerckJanuvia | $60 | $20,45914 claims |
| AstraZenecaFarxiga, Symbicort | $34 | $19,73634 claims |
| Sanofi-aventis U.S. LLCLantus | $21 | $3,86117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Mesa
- Terry O'ReillyMesa$35.8M
- Corey AndersonMesa$21.5M
- Gerald ShockeyMesa$12.3M
- Rachel GreatwoodMesa$1.5M
- Donna DesantisMesa$776K
- Yadwinder DhillonMesa$445K
- Benjamin ClarkMesa$441K
- Suzanne BentzMesa$174K
- William ReedyMesa$168K
- Allan SooMesa$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.